Form EFFECT Dianthus Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Announces Grand Opening of Prentis Branch in Scenic and Historic Rome, Georgia
- OBOOK Holdings Inc. (NASDAQ: OWLS) Announces Unaudited First Half 2026 Financial Results as OwlPay Harbor Commercial Scaling Accelerates
- Toppoint Holdings Announces Postponement of 2026 Annual Meeting of Stockholders to September 8, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share